Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DiarLock Vet is a veterinary feed supplement and therapeutic product developed by Navana Pharmaceuticals to manage and treat diarrhoea and support gastrointestinal health in livestock and pets. It is formulated as a powder containing a combination of active ingredients: zeolite and kaolin (which adsorb microbial toxins and act against microbes), oregano oil (which reduces microbial load and provides antibacterial, antiviral, and antifungal properties), pectin (which acts as an anti-diarrheal, adsorbent, and gut protectant), chestnut tannins (polyphenolic compounds with antibacterial, antiparasitic, antiviral, antioxidant, and anti-inflammatory effects), electrolytes (to restore electrolyte balance and maintain hydration), sugars (to provide instant energy), and plant extracts (to help reduce diarrhoea).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on DiarLock Vet.